Published on
April 19, 2023
- 11:29 GMT
Maxion Therapeutics awarded £2 million Innovate UK funding to develop ion channel antibodies for autoimmune diseases
• Targets critical unmet clinical need in autoimmunity, affecting ~300 million globally • Awarded as part of £25 million Innovate UK Biomedical Catalyst fund CAMBRIDGE, CAMBRIDGESHIRE, UNITED KINGDOM, April 19, 2023 /EINPresswire.com/ -- …
Distribution channels:
Business & Economy, Chemical Industry
...
